SAMC
ANIK icon

Shinko Asset Management Company’s Anika Therapeutics ANIK Stock Holding History

Shinko Asset Management Company’s Portfolio ANIK Stock Details ANIK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		$2.15M Sell
44,828
-12,891
-22% -$637K 0.01% 180
2016
Q2 		$3.1M Hold
57,719
– – 0.02% 141
2016
Q1 		$2.58M Buy
57,719
+43,595
+309% +$1.77M 0.02% 151
2015
Q4 		$539K Buy
+14,124
New +$540K ﹤0.01% 223

Other funds holding ANIK

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
TSW
Thompson Siegel & Walmsley Richmond, Virginia $5.7B AUM 6.69% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
AAM
AMI Asset Management Los Angeles, California $1.74B AUM 26.89% 1-Year Est. Return

Shinko Asset Management Company's ANIK Position: Q3 2016 in Review

Shinko Asset Management Company reduced its Anika Therapeutics (ANIK) stake by 22% in Q3 2016, selling an estimated $637K and leaving 44,828 shares worth $2.15M. The position accounts for 0.01% of the portfolio, ranked #180.

Shinko Asset Management Company first reported a position in ANIK in Q4 2015 and has held it in 4 quarters since. The position peaked at $3.1M in Q2 2016. 163 funds tracked by Wall St. Rank hold ANIK as of Q3 2016.

  • Shinko Asset Management Company held 44,828 shares of Anika Therapeutics worth $2.15M as of Q3 2016.
  • Shinko Asset Management Company sold 12,891 Anika Therapeutics shares in Q3 2016, an estimated $637K.
  • Anika Therapeutics made up 0.01% of Shinko Asset Management Company's portfolio in Q3 2016, its #180 holding.
  • Shinko Asset Management Company first reported a position in Anika Therapeutics in Q4 2015 and has held it in 4 quarters since.
  • Shinko Asset Management Company's Anika Therapeutics position peaked at $3.1M in Q2 2016.
  • 163 funds tracked by Wall St. Rank held Anika Therapeutics as of Q3 2016.

Based on Shinko Asset Management Company's 13F filing for Q3 2016, filed 24 Oct 2016.